Vilya
Seattle
About Vilya
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $71.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2024)
- Website: vilyatx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Medical
Canonical: https://fsome.com/organization/vilya-18062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.